✦ LIBER ✦

Dose-dense weekly docetaxel and CBDCA in adriamycin-resistant metastatic breast cancer (MBC)

✍ Scribed by Mehrdad Salimi; M.R. Mir

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly epirubicin in hormone-resistant m

✍ Tucci, E.; Bindi, M.; Crociani, M. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Efficacy of weekly paclitaxel in patient

✍ Kan Yonemori; Noriyuki Katsumata; Hajime Uno; Koji Matsumoto; Tsutomu Kouno; Shi 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 199 KB

Docetaxel toxicity and activity in anthr

✍ M. Milella; A. Vaccaro; V. Ferraresi; A.M. D'Ottavio; P. Papaldo; C. Nisticò; A. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Phase II Study of Weekly Paclitaxel for

✍ Tetsuya Taguchi; Tomohiko Aihara; Yuichi Takatsuka; Eisei Shin; Kazuyoshi Motomu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Weekly high-dose calcitriol and docetaxe

✍ T.M Beer; K.M Eilers; M Garzotto; M.J Egorin; B.A Lowe; W.D Henner; J.T Hsieh 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 21 KB

Metastatic breast cancer with resistance

✍ M. Ishitobi; E. Shin; N. Kikkawa 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 184 KB